Literature DB >> 22441765

High-fat diet obesity associated with insulin resistance increases cell proliferation, estrogen receptor, and PI3K proteins in rat ventral prostate.

Daniele Lisboa Ribeiro1, Maria Etelvina Pinto, Alex Rafacho, José Roberto Bosqueiro, Samantha Yuri Maeda, Janete Aparecida Anselmo-Franci, Sebastião Roberto Taboga, Rejane Maira Góes.   

Abstract

In this study, we evaluated the effects of obesity and insulin resistance induced by a high-fat diet on prostate morphophysiology, focusing on cell proliferation, expression of androgen (AR) and estrogen receptors (ER) and proteins of the insulin signaling pathway. Adult male Wistar rats were fed a high-fat diet (20% fat) for 15 weeks, whereas control animals received a balanced diet (4% fat). Both groups were then divided and treated for 2 weeks with 1 mg/kg body weight/day of the aromatase inhibitor letrozole or vehicle only. The ventral prostate was analyzed with immunohistochemical, histopathological, stereological, and Western blotting methods. Obese rats showed insulin resistance, hyperinsulinemia, and reduced plasma testosterone levels. The incidence of prostatic intraepithelial neoplasia (PIN) was 2.7 times higher in obese rats and affected 0.4% of the gland compared with 0.1% PIN areas found in control rats. Obesity doubled cell proliferation in both prostate epithelium and stroma. AR content decreased in the prostate of obese rats and estrogen receptor beta (ERβ) increased in this group. Protein levels of insulin receptor substrate 1 and protein kinase B diminished in the obese group, whereas phosphatidylinositol 3-kinase (PI3K) increased significantly. Most structural changes observed in the prostate of obese rats normalized after letrozole treatment, except for increased stromal cell proliferation and ERβ expression, which might be associated with insulin resistance. This experimental model of obesity and insulin resistance induced by a high-fat diet increases cell proliferation in rat prostate. Such alterations are associated with decreased levels of AR and increased ERβ and PI3K proteins. This change can facilitate the establishment of proliferative lesions in rat prostate.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22441765     DOI: 10.2164/jandrol.111.016089

Source DB:  PubMed          Journal:  J Androl        ISSN: 0196-3635


  10 in total

1.  Prostate hyperplasia caused by long-term obesity is characterized by high deposition of extracellular matrix and increased content of MMP-9 and VEGF.

Authors:  Silas Amâncio Silva; Marina Guimarães Gobbo; Maria Etelvina Pinto-Fochi; Alex Rafacho; Sebastião Roberto Taboga; Eduardo Alves Almeida; Rejane Maira Góes; Daniele Lisboa Ribeiro
Journal:  Int J Exp Pathol       Date:  2014-12-21       Impact factor: 1.925

Review 2.  Testosterone deficiency, insulin-resistant obesity and cognitive function.

Authors:  Hiranya Pintana; Nipon Chattipakorn; Siriporn Chattipakorn
Journal:  Metab Brain Dis       Date:  2015-02-24       Impact factor: 3.584

3.  Low body mass index is associated with adverse oncological outcomes following radical prostatectomy in Korean prostate cancer patients.

Authors:  Kyo Chul Koo; Young Eun Yoon; Koon Ho Rha; Byung Ha Chung; Seung Choul Yang; Sung Joon Hong
Journal:  Int Urol Nephrol       Date:  2014-05-10       Impact factor: 2.370

4.  Transitory FGF treatment results in the long-lasting suppression of the proliferative response to repeated FGF stimulation.

Authors:  Ashleigh Poole; Nicholas Knowland; Emily Cooper; Rebecca Cole; Hongchuan Wang; Lucas Booth; Doreen Kacer; Francesca Tarantini; Robert Friesel; Igor Prudovsky
Journal:  J Cell Biochem       Date:  2014-05       Impact factor: 4.429

5.  Diets rich in saturated and polyunsaturated fatty acids induce morphological alterations in the rat ventral prostate.

Authors:  Angélica Furriel; Pamella Campos-Silva; Paola Cariello Guedes Picarote Silva; Waldemar Silva Costa; Francisco José Barcellos Sampaio; Bianca Martins Gregório
Journal:  PLoS One       Date:  2014-07-16       Impact factor: 3.240

6.  Obesity and metabolic dysfunction severely influence prostate cell function: role of insulin and IGF1.

Authors:  Fernando L-López; André Sarmento-Cabral; Vicente Herrero-Aguayo; Manuel D Gahete; Justo P Castaño; Raúl M Luque
Journal:  J Cell Mol Med       Date:  2017-02-28       Impact factor: 5.310

7.  Phloretin exerts hypoglycemic effect in streptozotocin-induced diabetic rats and improves insulin resistance in vitro.

Authors:  Xin Shen; Nan Zhou; Le Mi; Zishuo Hu; Libin Wang; Xueying Liu; Shengyong Zhang
Journal:  Drug Des Devel Ther       Date:  2017-02-07       Impact factor: 4.162

Review 8.  Linking obesogenic dysregulation to prostate cancer progression.

Authors:  Renea A Taylor; Jennifer Lo; Natasha Ascui; Matthew J Watt
Journal:  Endocr Connect       Date:  2015-12       Impact factor: 3.335

9.  Oral kanglaite injection (KLTI) attenuates the lung cancer-promoting effect of high-fat diet (HFD)-induced obesity.

Authors:  Ning Cao; Xiaofang Ma; Zhenzhen Guo; Yaqiu Zheng; Shengnan Geng; Mingjing Meng; Zhenhua Du; Haihong Lin; Yongjian Duan; Gangjun Du
Journal:  Oncotarget       Date:  2016-09-20

Review 10.  Diet-Induced Hyperinsulinemia as a Key Factor in the Etiology of Both Benign Prostatic Hyperplasia and Essential Hypertension?

Authors:  Wolfgang Kopp
Journal:  Nutr Metab Insights       Date:  2018-05-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.